Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia

Leukemia. 2019 Jan;33(1):249-278. doi: 10.1038/s41375-018-0192-z. Epub 2018 Jun 28.

Carolina Vicente-Dueñas¹, Inés González-Herrero^{1

2}, Lalit Sehgal³, Idoia García-Ramírez^{1

2}, Guillermo Rodríguez-Hernández^{1

2}, Belén Pintado⁴, Oscar Blanco^{1

5}, Francisco Javier García Criado^{1

6}, María Begoña García Cenador^{1

6}, Michael R Green^{7

8

9}, Isidro Sánchez-García^{10

11}

¹ Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
² Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
³ Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Transgenesis Facility CNB-CBMSO, CSIC-UAM, Madrid, Spain.
⁵ Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.
⁶ Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain.
⁷ Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
⁸ Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
⁹ Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
¹⁰ Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. isg@usal.es.
¹¹ Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain. isg@usal.es.

No abstract available

Publication types